Vincent Lo Re

Nov 6, 2024 | jamanetwork.com | Janet P. Tate |Joseph Lim |Jessie Torgersen |Vincent Lo Re

Key PointsQuestion  Can risk factors for hepatocellular carcinoma (HCC) among adults without viral hepatitis or decompensated cirrhosis be identified and used to develop a risk score to inform screening? Findings  In a cohort study of 6 509 288 patients in the Veterans Affairs health care system, a risk score was developed using the Fibrosis-4 Index, age, sex, race and ethnicity, body mass index, diabetes status, smoking status, and alcohol use.

Nov 4, 2024 | jamanetwork.com | Vincent Lo Re |Jessie Torgersen |Amy C. Justice |Alyssa K. Mezochow

Risk of Liver Injury With Potentially Hepatotoxic Drugs—Reply Severe Acute Liver Injury After Hepatotoxic Medication Initiation Jessie Torgersen, MD, MHS, MSCE; Alyssa K. Mezochow, MD; Craig W. Newcomb, MS; Dean M. Carbonari, MS; Sean Hennessy, PharmD, PhD; Christopher T. Rentsch, PhD; Lesley S. Park, PhD; Janet P. Tate, ScD; Norbert Bräu, MD; Debika Bhattacharya, MD; Joseph K. Lim, MD; Catherine Mezzacappa, MD; Basile Njei, MD, PhD; Jason A. Roy, PhD; Tamar H.

May 25, 2023 | jamanetwork.com | Robert Gross |Vincent Lo Re |Tanayott Thaweethai |Sarah E. Jolley

Disentangling the Postacute Sequelae of SARS-CoV-2: E Unibus Pluram (From One, Many) Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection Tanayott Thaweethai, PhD; Sarah E. Jolley, MD, MS; Elizabeth W. Karlson, MD, MS; Emily B. Levitan, ScD; Bruce Levy, MD; Grace A. McComsey, MD; Lisa McCorkell, MPP; Girish N. Nadkarni, MD, MPH; Sairam Parthasarathy, MD; Upinder Singh, MD; Tiffany A. Walker, MD; Caitlin A. Selvaggi, MS; Daniel J. Shinnick, MS; Carolin C.